ArticleJournal of clinical medicine2021

Adjuvant Lineage-Negative Cell Therapy as a Potential Silencer of the Complement-Mediated Immune System in ALS Patients.

Anna Sobuś et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.